AlanMRapoportMD
Neurology • Beverly Hills, CAHeadache
Clinical Professor of Neurology, David Geffen School of Medicine at UCLA; Private Practice Neurologist, California Medical Clinic for Headache; Founder and Director-Emeritus of the New England Center for Headache; Founding President of the Headache Cooperative of New England.
Dr. Rapoport is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
415 North Crescent Drive
Suite # 300
Beverly Hills, CA 90210Phone+1 310-315-1456- Is this information wrong?
Summary
- Clinical Professor of Neurology at the David Geffen School of Medicine at UCLA in Los Angeles and has a private practice in Beverly Hills, California. He a past president of the International Headache Society, the Founder and Director-Emeritus of the New England Center for Headache in Stamford, Connecticut, and the Founding President of the Headache Cooperative of New England.
Dr. Rapoport has written over 350 articles on headache and Co Authored 9 books for doctors, nurses and patients. He is the CEO and Co-Founder of BonTriage, a medical IT company helping patients to obtain more accurate diagnoses and better outcomes.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 1967 - 1970
Maimonides Medical CenterInternship, Internal Medicine, 1966 - 1967
State University of New York Downstate Medical Center College of MedicineClass of 1966
Certifications & Licensure
CA State Medical License 2004 - 2024
CT State Medical License 1971 - 2009
NY State Medical License 1967 - 2007
FL State Medical License 1973 - 2007- American Board of Psychiatry and Neurology Neurology
- UCNSHeadache Medicine
Clinical Trials
- Preventive Treatment of Episodic and Chronic Migraine Start of enrollment: 2011 Apr 01
- Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunction.Christian Lampl, Alan M Rapoport, Joshua M Cohen, Steve Barash, Verena Ramirez Campos, Michael J Seminerio, Xiaoping Ning, Stephen D Silberstein> ;European Journal of Neurology. 2022 Jul 1
- 2 citationsNeurobiology of migraine progression.Wanakorn Rattanawong, Alan Rapoport, Anan Srikiatkhachorn> ;Neurobiology of Pain. 2022 Jun 9
- Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi-center study.Robert P Cowan, Alan M Rapoport, Jim Blythe, John Rothrock, Kerry Knievel, Addie M Peretz, Elizabeth Ekpo, Bharati M Sanjanwala, Yohannes W Woldeamanuel> ;Headache. 2022 Jul 1
- Join now to see all
Press Mentions
Petadolex for Migraine Prevention Concluded SafeJanuary 24th, 2020
American Headache Society Publishes Article Demonstrating the Promise of Remote Electrical Neuromodulation (REN) as First-Line Treatment for Acute Migraine ReliefNovember 8th, 2019
Relivion Headset for Migraines Cleared in EuropeJuly 12th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
